1. Home
  2. Buyout

Category: healthtech

SEMCAP branches into healthtech with launch of $400m fundraise

Private equity investor SEMCAP has launched a new healthcare investing strategy with eyes on a $400m fundraise. The post SEMCAP branches into healthtech with launch of $400m fundraise first appeared on AltAssets Private Equity News.

Digitalis Ventures targets breakout healthtech with new $300m fund close

Health investor Digitalis Ventures has hit a $300m final close for its fourth fund. The post Digitalis Ventures targets breakout healthtech with new $300m fund close first appeared on AltAssets Private Equity News.

Oxford University investment partner OSE raises £250m to back groundbreaking next-gen science startups

University of Oxford-partnering investment firm Oxford Science Enterprises has raised £250m to drive the creation and growth of businesses built on ground-breaking science from the hallowed institution. The post Oxford University investment partner OSE raises

HealthTech investor Flare Capital strikes $350m goal in third flagship fundraise

HealthTech-focused Flare Capital Partners has reached the $350m target for its third flagship fundraise. The post HealthTech investor Flare Capital strikes $350m goal in third flagship fundraise first appeared on AltAssets Private Equity News.

Chiratae Ventures looking to raise $700m for Indian tech investment – report

Indian venture capital firm Chiratae Ventures is looking to raise $700m to invest in the tech sector in India, AVCJ reported. The post Chiratae Ventures looking to raise $700m for Indian tech investment – report

Warburg Pincus partners with Mubadala to acquire Pharma Intelligence, eyeing the $22bn pharma analytics market

Global buyout major Warburg Pincus, has partnered with Abu Dhabi-based investment firm Mubadala to acquire Pharma Intelligence from London-listed Informa. The post Warburg Pincus partners with Mubadala to acquire Pharma Intelligence, eyeing the $22bn pharma

Lauxera smashes target for debut fund looking to expand booming European healthtech to US market

Lauxera Capital Partners has raised one of Europe's biggest healthtech-focused fundraises with its debut vehicle by soaring past its target to reach a €260m final close. The post Lauxera smashes target for debut fund looking

Tramway Venture Partners banking on New Mexico attractiveness as it launches debut fundraise

New Mexico-based Tramway Venture Partners is out raising its debut fund, with a focus on biotech, medtech and healthtech deals.

We use cookies to offer you a better browsing experience. If you continue to use this site, you consent to our use of cookies.
We use cookies to offer you a better browsing experience. If you continue to use this site, you consent to our use of cookies.